MyoGene Bio is selected to participate in Startup Battlefield 200 at TechCrunch Disrupt 2026

August 24, 2026

MyoGene Bio has been chosen to exhibit at TechCrunch Disrupt 2026 as part of Startup Battlefield 200, the world’s preeminent startup competition. We were one of 200 startups selected from a review of thousands of applicants to pitch in front of investors and TechCrunch editors. This year’s Startup Battlefield participants span healthtech, manufacturing/industrial, SaaS, defense, sustainability, space exploration, consumer products and more. TechCrunch Disrupt 2026 will be held from Oct. 13 - Oct. 15 at Moscone West in San Francisco. The event is known for debuting the hottest startups, introducing game-changing technologies and discussing what’s top-of-mind for the tech industry’s key innovators—and this year will be no different. MyoGene is honored and thankful to have been selected and looks forward to exhibiting and pitching.

 Read more here: https://techcrunch.com/2026/08/20/the-2026-startup-battlefield-200-is-here-see-who-made-the-cut/